Then, enhanced viral growth occurs at a higher dilution. At some dilution of antibody, optimal viral
infections occur and peak enhancement is observed. At a still higher dilution, the concentration of infectious antibody–virus complexes is not great enough to elicit the system response and the infection enhancement is gradually lost [64]. The peak infection enhancement also need a large number of virus receptors on FcR-bearing cells, the efficient cell entry of virus, the viability of virus in the cytosol, and capability to accomplish all steps to achieve assembly and final release of virus particles. Since recent studies found that DENV GS-1101 research buy particles released from infected cells contained as many as 30% prM particles, the infectious potential LY333531 of immature particles may have significant implications for understanding of the dengue pathogenesis. In the early stages of a primary infection, immature particles fail to enter host cells in the absence of antibodies, and therefore are of minor importance in disease development. On the other hand, prM-specific antibody response will activate the infectivity of fully immature particle upon secondary infection, and increase the number of infectious particles. The epitope recognized by our own anti-prM antibody was located in amino acid residuals 14–18 of the prM protein and
was different from the published sequence recognized by other anti-prM mAb 2H2 (mapped to amino acid residuals 40–49) and 70-21 (mapped to amino acid residuals 53–67) [40, 41].
Previous studies have shown that 2H2 provided buy RXDX-101 cross-protection against all four DENV serotypes [40, 55]. However, Farnesyltransferase many studies demonstrated that 2H2 could enhance the infectivity of standard DENVV and imDENV [27, 65, 66]. Also, antibody 70–21 as well as many other prM mAbs has been reported to enhance DENV infectivity [24, 26, 27, 31]. Our results support that anti-prM antibodies could enhance infectious properties of DENV and prM epitopes could be not protective but infection enhancing. We propose that the length of epitope sequence has an important role to mediate ADE infection. For long epitope peptide sequences, they may contain two or more epitopes, which may be immunodominant or cryptic. These findings suggest that antigenic structures of prM and their functions are complicated and not well studied. Most current dengue vaccines contain native dengue prM, it may be important to consider better vaccine approaches that eliminate ADE activities induced by infection-enhancing epitopes on prM during vaccine design [24]. Vaccine candidates that eliminate pathogenic infection-enhancing epitopes may thus become increasingly important. Most importantly, identification of the epitopes on prM protein will provide new insights for further understanding of humoral immune responses to DENV at the epitope level.